HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
NNOX
Nano-X Imaging Ltd.
NNOX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
NNOX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
NNOX's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
NNOX PE Valuation
NNOX has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
NNOX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect NNOX's losses to shrink, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
NNOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.70 | -$0.80 |
| Q1 2026 | -$1.14 | -$0.24 |
| Q4 2025 | -$1.15 | -$0.25 |
| Q3 2025 | -$0.88 | -$0.03 |
| Q2 2025 | -$0.90 | +$0.09 |
| Q1 2025 | -$0.90 | +$0.17 |
| Q4 2024 | -$0.90 | +$0.17 |
| Q3 2024 | -$0.85 | +$0.90 |
NNOX is still losing money, but less than at its worst: $1.70 per share over the past year, against $2.03 at its worst in late 2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over NNOX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over NNOX on profitability, with a higher operating margin.
NNOX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.2M | +37% |
| Q1 2026 | $4.3M | +53% |
| Q4 2025 | $3.7M | +24% |
| Q3 2025 | $3.4M | +14% |
| Q2 2025 | $3M | +13% |
| Q1 2025 | $2.8M | +10% |
| Q4 2024 | $3M | +25% |
| Q3 2024 | $3M | +22% |
NNOX's revenue has grown year over year for 19 quarters in a row: $4M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1335% | -858 points |
| Q1 2026 | -343% | +157 points |
| Q4 2025 | -481% | +18 points |
| Q3 2025 | -413% | +54 points |
| Q2 2025 | -477% | +61 points |
| Q1 2025 | -501% | +12 points |
| Q4 2024 | -499% | +54 points |
| Q3 2024 | -466% | +421 points |
NNOX's operating margin was −1335% last quarter, down 858 points from the same quarter a year ago, near the bottom of its range since 2021.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over NNOX on cash generation, producing positive trailing cash flow while its opponent burns cash.
NNOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$12.6M | -$2.2M |
| Q1 2026 | -$15.7M | -$4.9M |
| Q4 2025 | -$12.5M | -$922.8K |
| Q3 2025 | -$12.5M | -$3.6M |
| Q2 2025 | -$10.4M | -$1M |
| Q1 2025 | -$10.9M | -$1.3M |
| Q4 2024 | -$11.6M | +$890.5K |
| Q3 2024 | -$8.9M | +$3.5M |
NNOX has burned cash in almost every quarter: −$53M over the past year, against −$42M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over NNOX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
NNOX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +312K shares |
| 1 year | +9.4% | +6M shares |
| 3 years | +26% | +14.6M shares |
| 5 years | +46% | +22.2M shares |
| Available history | +105% | +35.8M shares |
NNOX has 70M diluted shares, up 9.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NNOX hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
NNOX Net Leverage
NNOX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
NNOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.9 | Oversold |
| Stochastic | 7.0 | Oversold |
NNOX's weekly RSI is 27 (oversold) and its Stochastic is 7 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
NNOX PE vs Healthcare Sector
NNOX has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
NNOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.44 | 27% below |
| 20 week MA | $0.75 | 57% below |
| 50 week MA | $1.73 | 82% below |
| 100 week MA | $3.50 | 91% below |
| 200 week MA | $6.06 | 95% below |
NNOX is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over NNOX on returns for 2026, with the stronger performance.
NNOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $49.6 | $52.5 | +5.7% |
| 2021 | $52.5 | $17.9 | -66% |
| 2022 | $17.9 | $8.02 | -55% |
| 2023 | $8.02 | $6.37 | -21% |
| 2024 | $6.37 | $7.59 | +19% |
| 2025 | $7.59 | $2.86 | -62% |
| 2026 YTD | $2.86 | $0.32 | -89% |
NNOX has finished lower in four of the last six years. It's down 89% so far in 2026.